COLL vs GPC · P/E 17, rev $181.9M vs P/E 21, rev $23.49B
Collegium Pharmaceutical Inc (COLL) versus Genuine Parts Co (GPC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Not investment advice. Open the COLL and GPC stock pages for the full models.
Not investment advice.